Mesenchymal Stromal Cells Derived from Human Embryonic Stem Cells, Fetal Limb and Bone Marrow Share a Common Phenotype but Are Transcriptionally and Biologically Different
Mesenchymal stromal cells (MSCs) can be obtained from several sources and the significant differences in their properties make it crucial to investigate the differentiation potential of MSCs from different sources to determine the optimal source of MSCs. We investigated if this biological heterogeneity in MSCs from different sources results in different mechanisms for their differentiation. In this study, we compared the gene expression patterns of phenotypically defined MSCs derived from three ontogenically different sources: Embryonic stem cells (hES-MSCs), Fetal limb (Flb-MSCs) and Bone Marrow (BM-MSCs). Differentially expressed genes between differentiated cells and undifferentiated controls were compared across the three MSC sources. We found minimal overlap (5% - 16%) in differentially expressed gene sets among the three sources. Flb-MSCs were similar to BM-MSCs based on differential gene expression patterns. Pathway analysis of the differentially expressed genes using Ingenuity Pathway Analysis (IPA) revealed a large variation in the canonical pathways leading to MSC differentiation. The similar canonical pathways among the three sources were lineage specific. The Flb-MSCs showed maximum overlap of canonical pathways with the BM-MSCs, indicating that the Flb-MSCs are an intermediate source between the less specialised hES-MSC source and the more specialised BM-MSC source. The source specific pathways prove that MSCs from the three ontogenically different sources use different biological pathways to obtain similar differentiation outcomes. Thus our study advocates the understanding of biological pathways to obtain optimal sources of MSCs for various clinical applications.
Prockop, D.J. (1997) Marrow Stromal Cells as Stem Cells for Nonhematopoietic Tissues. Science, 276, 71-74. https://doi.org/10.1126/science.276.5309.71
[3]
Bianco, P., Riminucci, M., Gronthos, S. and Robey, P.G. (2001) Bone Marrow Stromal Stem Cells: Nature, Biology, and Potential Applications. Stem Cells, 19, 180-192. https://doi.org/10.1634/stemcells.19-3-180
[4]
Minguell, J.J., Erices, A. and Conget, P. (2001) Mesenchymal Stem Cells. Experimental Biology and Medicine, 226, 507-520.
[5]
Horwitz, E.M., Le Blanc, K., Dominici, M., Mueller, I., Slaper-Cortenbach, I., Marini, F.C., Deans, R.J., Krause, D.S. and Keating, A. (2005) Clarification of the Nomenclature for MSC: The International Society for Cellular Therapy Position Statement. Cytotherapy, 7, 393-395. https://doi.org/10.1080/14653240500319234
[6]
Caplan, A.I. (1994) The Mesengenic Process. Clinics in Plastic Surgery, 21, 429-435.
[7]
Pittenger, M.F., Mackay, A.M., Beck, S.C., Jaiswal, R.K., Douglas, R., Mosca, J.D., Moorman, M.A., Simonetti, D.W., Craig, S. and Marshak, D.R. (1999) Multilineage Potential of Adult Human Mesenchymal Stem Cells. Science, 284, 143-147. https://doi.org/10.1126/science.284.5411.143
[8]
Krebsbach, P.H., Kuznetsov, S.A., Bianco, P. and Robey, P.G. (1999) Bone Marrow Stromal Cells: Characterization and Clinical Application. Critical Reviews in Oral Biology & Medicine, 10, 165-181. https://doi.org/10.1177/10454411990100020401
[9]
Zuk, P.A., Zhu, M., Mizuno, H., Huang, J., Futrell, J.W., Katz, A.J., Benhaim, P., Lorenz, H.P. and Hedrick, M.H. (2001) Multilineage Cells from Human Adipose Tissue: Implications for Cell-Based Therapies. Tissue Eng, 7, 211-228. https://doi.org/10.1089/107632701300062859
[10]
De Bari, C., Dell’Accio, F., Tylzanowski, P. and Luyten, F.P. (2001) Multipotent Mesenchymal Stem Cells from Adult Human Synovial Membrane. Arthritis & Rheumatology, 44, 1928-1942. https://doi.org/10.1002/1529-0131(200108)44:8<1928::AID-ART331>3.0.CO;2-P
[11]
De Bari, C., Dell’Accio, F. and Luyten, F.P. (2001) Human Periosteum-Derived Cells Maintain Phenotypic Stability and Chondrogenic Potential throughout Expansion Regardless of Donor Age. Arthritis & Rheumatology, 44, 85-95. https://doi.org/10.1002/1529-0131(200101)44:1<85::AID-ANR12>3.0.CO;2-6
[12]
Maxim, M.A., Soritau, O., Baciut, M., Bran, S. and Baciut, G. (2015) The Role of Dental Stem Cells in Regeneration. Clujul Medical, 88, 479-482. https://doi.org/10.15386/cjmed-475
[13]
O’Donoghue, K. and Chan, J. (2006) Human Fetal Mesenchymal Stem Cells. Current Stem Cell Research & Therapy, 1, 371-386. https://doi.org/10.2174/157488806778226768
[14]
In’t Anker, P.S., Scherjon, S.A., Kleijburg-van der Keur, C., Noort, W.A., Claas, F.H., Wil-lemze, R., Fibbe, W.E. and Kanhai, H.H. (2003) Amniotic Fluid as a Novel Source of Mesenchymal Stem Cells for Therapeutic Transplantation. Blood, 102, 1548-1549. https://doi.org/10.1182/blood-2003-04-1291
[15]
Kim, D.W., Staples, M., Shinozuka, K., Pantcheva, P., Kang, S.D. and Borlongan, C.V. (2013) Wharton’s Jelly-Derived Mesenchymal Stem Cells: Phenotypic Characterization and Optimizing Their Therapeutic Potential for Clinical Applications. International Journal of Molecular Sciences, 14, 11692-11712. https://doi.org/10.3390/ijms140611692
[16]
Lee, O.K., Kuo, T.K., Chen, W.M., Lee, K.D., Hsieh, S.L. and Chen, T.H. (2004) Isolation of Multipotent Mesenchymal Stem Cells from Umbilical Cord Blood. Blood, 103, 1669-1675. https://doi.org/10.1182/blood-2003-05-1670
[17]
Via, A.G., Frizziero, A. and Oliva, F. (2012) Biological Properties of Mesenchymal Stem Cells from Different Sources. Muscle, Ligaments and Tendons Journal, 2, 154-162.
[18]
Mareschi, K., Ferrero, I., Rustichelli, D., Aschero, S., Gammaitoni, L., Aglietta, M., Madon, E. and Fagioli, F. (2006) Expansion of Mesenchymal Stem Cells Isolated from Pediatric and Adult Donor Bone Marrow. Journal of Cellular Biochemistry, 97, 744-754. https://doi.org/10.1002/jcb.20681
[19]
Sun, L.Y., Hsieh, D.K., Syu, W.S., Li, Y.S., Chiu, H.T. and Chiou, T.W. (2010) Cell Proliferation of Human Bone Marrow Mesenchymal Stem Cells on Biodegradable Microcarriers Enhances in Vitro Differentiation Potential. Cell Proliferation, 43, 445-456. https://doi.org/10.1111/j.1365-2184.2010.00694.x
[20]
Yoshimura, H., Muneta, T., Nimura, A., Yokoyama, A., Koga, H. and Sekiya, I. (2007) Comparison of Rat Mesenchymal Stem Cells Derived from Bone Marrow, Synovium, Periosteum, Adipose Tissue, and Muscle. Cell and Tissue Research, 327, 449-462. https://doi.org/10.1007/s00441-006-0308-z
[21]
Fraser, J.K., Wulur, I., Alfonso, Z. and Hedrick, M.H. (2006) Fat Tissue: An Underappreciated Source of Stem Cells for Biotechnology. Trends in Biotechnology, 24, 150-154.
[22]
Hass, R., Kasper, C., Bohm, S. and Jacobs, R. (2011) Different Populations and Sources of Human Mesenchymal Stem Cells (MSC): A Comparison of Adult and Neonatal Tissue-Derived MSC. Cell Communication and Signaling, 9, 12. https://doi.org/10.1186/1478-811x-9-12
[23]
Cavallo, C., Cuomo, C., Fantini, S., Ricci, F., Tazzari, P. L., Lucarelli, E., Donati, D., Facchini, A., Lisignoli, G., Fornasari, P.M., Grigolo, B. and Moroni, L. (2011) Comparison of Alternative Mesenchymal Stem Cell Sources for Cell Banking and Musculoskeletal Advanced Therapies. Journal of Cellular Biochemistry, 112, 1418-1430. https://doi.org/10.1002/jcb.23058
[24]
Jin, H.J., Bae, Y.K., Kim, M., Kwon, S.J., Jeon, H.B., Choi, S.J., Kim, S.W., Yang, Y.S., Oh, W. and Chang, J.W. (2013) Comparative Analysis of Human Mesenchymal Stem Cells from Bone Marrow, Adipose Tissue, and Umbilical Cord Blood as Sources of Cell Therapy. International Journal of Molecular Sciences, 14, 17986-18001. https://doi.org/10.3390/ijms140917986
[25]
Liu, T.M., Martina, M., Hutmacher, D.W., Hui, J.H., Lee, E.H. and Lim, B. (2007) Identification of Common Pathways Mediating Differentiation of Bone Marrow and Adipose Tissue-Derived Human Mesenchymal Stem Cells into Three Mesenchymal Lineages. Stem Cells, 25, 750-760. https://doi.org/10.1634/stemcells.2006-0394
[26]
Wegmeyer, H., Broske, A.M., Leddin, M., Kuentzer, K., Nisslbeck, A.K., Hupfeld, J., Wiech-mann, K., Kuhlen, J., von Schwerin, C., Stein, C., Knothe, S., Funk, J., Huss, R. and Neubauer, M. (2013) Mesenchymal Stromal Cell Characteristics Vary Depending on Their Origin. Stem Cells and Development, 22, 2606-2618. https://doi.org/10.1089/scd.2013.0016
[27]
Djouad, F., Bony, C., Haupl, T., Uze, G., Lahlou, N., Louis-Plence, P., Apparailly, F., Canovas, F., Reme, T., Sany, J., Jorgensen, C. and Noel, D. (2005) Transcriptional Profiles Discriminate Bone Marrow-Derived and Synovium-Derived Mesenchymal Stem Cells. Arthritis Research & Therapy, 7, R1304-R1315. https://doi.org/10.1186/ar1827
[28]
Wang, S., Qu, X. and Zhao, R.C. (2012) Clinical Applications of Mesenchymal Stem Cells. Journal of Hematology & Oncology, 5, 19. https://doi.org/10.1186/1756-8722-5-19
[29]
Caplan, A.I. and Bruder, S.P. (2001) Mesenchymal Stem Cells: Building Blocks for Molecular Medicine in the 21st Century. Trends in Molecular Medicine, 7, 259-264.
[30]
Reiser, J., Zhang, X.Y., Hemenway, C.S., Mondal, D., Pradhan, L. and La Russa, V.F. (2005) Potential of Mesenchymal Stem Cells in Gene Therapy Approaches for Inherited and Acquired Diseases. Expert Opinion on Biological Therapy, 5, 1571-1584. https://doi.org/10.1517/14712598.5.12.1571
[31]
Patel, D.M., Shah, J. and Srivastava, A.S. (2013) Therapeutic Potential of Mesenchymal Stem Cells in Regenerative Medicine. Stem Cells International, 2013, Article ID: 496218. https://doi.org/10.1155/2013/496218
[32]
Lai, R.C., Choo, A. and Lim, S.K. (2011) Derivation and Characterization of Human ESC-Derived Mesenchymal Stem Cells. Methods in Molecular Biology, 698, 141-150. https://doi.org/10.1007/978-1-60761-999-4_11
[33]
Lai, R.C., Arslan, F., Tan, S.S., Tan, B., Choo, A., Lee, M.M., Chen, T.S., Teh, B.J., Eng, J.K., Sidik, H., Tanavde, V., Hwang, W.S., Lee, C.N., El Oakley, R.M., Pasterkamp, G., de Kleijn, D.P., Tan, K.H. and Lim, S.K. (2010) Derivation and Characterization of Human Fetal MSCs: An Alternative Cell Source for Large-Scale Production of Cardioprotective Microparticles. Journal of Molecular and Cellular Cardiology, 48, 1215-1224.
[34]
Ng, F., Boucher, S., Koh, S., Sastry, K.S., Chase, L., Lakshmipathy, U., Choong, C., Yang, Z., Vemuri, M.C., Rao, M.S. and Tanavde, V. (2008) PDGF, TGF-Beta, and FGF Signaling Is Important for Differentiation and Growth of Mesenchymal Stem Cells (MSCs): Transcriptional Profiling Can Identify Markers and Signaling Pathways Important in Differentiation of MSCs into Adipogenic, Chondrogenic, and Osteogenic Lineages. Blood, 112, 295-307. https://doi.org/10.1182/blood-2007-07-103697
[35]
Brown, P.T., Squire, M.W. and Li, W.J. (2014) Characterization and Evaluation of Mesenchymal Stem Cells Derived from Human Embryonic Stem Cells and Bone Marrow. Cell Tissue Research, 358, 149-164. https://doi.org/10.1007/s00441-014-1926-5
[36]
Tanavde, V., Vaz, C., Rao, M.S., Vemuri, M.C. and Pochampally, R.R. (2015) Research Using Mesenchymal Stem/Stromal Cells: Quality Metric towards Developing a Reference Material. Cytotherapy, 17, 1169-1177.
